Scientia Advisors in the News

---

Publications

---

Press Releases

---

Events

---

Luminary Insights

---

Media Contact

---

Conferences

Licensing Executives Society (LES) 2011 Annual Meeting: Harry Glorikian moderates session on "Convergence of Devices/Diagnostics and Pharmaceuticals"

Topic

Impact of New Technologies on Licensing and Partnering
Is the era of standalone drug therapy waning? Enter the era of personalized medicine, where convergence of therapeutics and companion diagnostics (and devices) may be necessary for success. Additionally, the availability of personalized genetic tests that allow individuals to see which diseases they may be susceptible to could lead to "patients" seeking "early treatment." Come listen to this panel of experts at the forefront of personalized therapeutics, diagnostics and device convergence to learn how these new technologies will impact healthcare in the future as well as the implications on licensing & partnering. Case studies involving recent transactions will be discussed.

Moderator

• Harry Glorikian, Managing Partner, SCIENTIA ADVISORS

Panelists

• Mara Aspinall, President & CEO, ON-Q-ITY
• James Datin, EVP and Managing Director of Lifesciences, SAFEGUARD SCIENTIFICS
• Hakan Sakul, Senior Director, Translational Oncology Group, PFIZER

More information at the Licensing Executives Society Website.